Tivic Health Systems, Inc. TIVC
Set alert
0.26 USD 0.00 0.00%
As of Jul 29, 3:59 PM ET
0.2531 Day range 0.2842
0.201 52-week range 2.24
- YTD
- -82.23%
- 1 year
- -93.22%
- Open
- 0.2842
- Prev close
- 0.2577
- Mkt cap
- 1.85M
- Vol
- 130.89K
- Avg vol
- 5.67M
- EPS
- 5.37
- P/E
- 0.04
- Div yield
- 0.00%
More statistics
- Low
- 0.2531
- High
- 0.2842
- Forward P/E
- -0.01
- Beta
- 2.41
- Short ratio
- 0.12
- Inst. own
- 3.64%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 25, 2024
- 50-d avg
- 0.27238
- 200-d avg
- 0.52189
- 1y target
- 0.00
Key statistics
- Market cap
- 1.85M
- Enterprise value
- -1.90M
- Trailing P/E
- 0.04
- Forward P/E
- -0.01
- PEG ratio
- 0.00
- Price / sales
- 1.67
- Price / book
- 0.09
- EPS (TTM)
- 5.37
- Beta
- 2.41
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.11M
- Revenue growth
- -13.00%
- Free cash flow
- -3.81M
- Total cash
- 3.69M
- Total debt
- 0
- Return on equity
- -183.60%
- Shares outstanding
- 8.27M
- Short % of float
- 1.81%
- 50-day average
- 0.27238
- 200-day average
- 0.52189
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Mar 25, 2024
Expected Mar 25, 2024. Consensus EPS estimate 0.00.
Financials — quick view
TIVC Revenue — quarterly -302.00K
TIVC Net income — quarterly -2.85M
TIVC EPS — quarterly -1.35
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.23 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.32 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -1.01 | — | — |
| Mar 25, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | -7.00 | -1.48 | +5.52 | +78.86% |
| Aug 14, 2023 | Jun 1, 2023 | -8.00 | -7.00 | +1.00 | +12.50% |
About Tivic Health Systems, Inc.
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- tivichealth.com
News
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model
- Tivic Health Systems (NASDAQ:TIVC) Director Sheryle Bolton Purchases 10,000 Shares of Stock
- Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Reviewing Omnicell (NASDAQ:OMCL) & Tivic Health Systems (NASDAQ:TIVC)
- Tivic Health Systems Touts Entolimod Phase 3 ARS Path, Eyes BLA in 2027-2028 at Conference
- Financial Comparison: Tivic Health Systems (NASDAQ:TIVC) versus Rennova Health (OTCMKTS:RNVA)
- 12 Health Care Stocks Moving In Thursday's After-Market Session
Your note
Sign in to keep a note on TIVC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAMBACH KIMBERLY ANN | Chief Financial Officer | Stock Award(Grant) | Mar 11, 2024 | 7,500 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 1.14% | 94,298 | 21.16K | Sep 29, 2024 |
| Vanguard Group Inc | 0.58% | 47,981 | 10.77K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.44% | 36,457 | 8.18K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.35% | 28,522 | 6.40K | Sep 29, 2024 |
| Virtu Financial LLC | 0.25% | 20,944 | 4.70K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.22% | 18,358 | 4.12K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.58% | 47,981 | 10.77K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.37% | 30,668 | 6.88K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.02% | 1,717 | 385 | Oct 30, 2024 |